News

Drug Price Regulations: Is Pfizer Stock A Buy Or Sell?
Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...
MedPage Today on MSN23h
Pfizer Confirms: Leading JAK Inhibitor Often Comes With Weight Gain
After 6 months, placebo was associated with a mean weight gain of 0.4 kg (o.88 lb), compared with 1.2-1.9 kg (2.6-4.2 lb) ...
Pfizer subsidiary receives A2 rating from Moody’s with stable outlook
Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a ...
Wondering if Pfizer's 7.6% Dividend Yield Is Sustainable? Here's What You Need to Know.
But when a dividend yield reaches ultrahigh levels, investors can feel a heightened level of uncertainty. Wondering if Pfizer ...
Trump’s Plan to Cut Drug Prices Hits Pfizer, Other Pharma Stocks
Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...
Why Pfizer Inc. (PFE) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom
Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands ...
Pfizer: Bearish Catalysts Brewing
Pfizer's 7.45% dividend yield can't offset weak growth, declining EPS, and patent risks. Read more on PFE and why analysts ...
Euractiv1h
Parliament celebrates Pfizer decision as victory against Commission’s secrecy
After an EU court ruled that Ursula von der Leyen should have published text messages she exchanged with the CEO of Pfizer, MEPs across all party lines have welcomed the decision as a victory against ...